Antonio Chirianni
- Virology top 2%
- HIV Research and Treatment 30
- Emergency Medicine top 1%
- HIV-related health complications and treatments 22
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 20
- HIV/AIDS Research and Interventions 12
- Hepatology top 5%
- Hepatitis C virus research 10
- Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Liver Disease Diagnosis and Treatment 6
-
- Systemic Lupus Erythematosus Research 5
- Co-authors
- Paolo MaggiMarcello PiazzaAntonio LilloFrancesco PerilliGiuseppina LiuzziMassimo ClementiMiriam GargiuloGioacchino Angarano
- Journals
- Hepatology (2 papers)Clinical Cancer Research (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Antonio Chirianni
68 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Virology 429
- Emergency Medicine 444
- Infectious Diseases 553
- Hepatology 170
- Epidemiology 292
Countries citing papers authored by Antonio Chirianni
This map shows the geographic impact of Antonio Chirianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Chirianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Chirianni more than expected).
Fields of papers citing papers by Antonio Chirianni
This network shows the impact of papers produced by Antonio Chirianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Chirianni. The network helps show where Antonio Chirianni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Chirianni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 4 | |
| 2 | 2018 | 12 | |
| 3 | 2018 | 7 | |
| 4 | 2018 | 2 | |
| 5 | 2017 | 22 | |
| 6 | 2012 | 19 | |
| 7 | 2012 | 9 | |
| 8 | 2009 | 7 | |
| 9 | 2007 | 8 | |
| 10 | 2004 | 27 | |
| 11 | 2004 | 80 | |
| 12 | 2001 | 11 | |
| 13 | 2000 | 196 | |
| 14 | 90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. | 1998 | 7 |
| 15 | 1996 | 126 | |
| 16 | 1995 | 16 | |
| 17 | 1994 | 17 | |
| 18 | 1992 | 2 | |
| 19 | [Oral hairy leukoplakia]. | 1990 | 1 |
| 20 | [Cerebral toxoplasmosis in subjects with acquired immunodeficiency syndrome]. | 1989 | 1 |
About Antonio Chirianni
Antonio Chirianni is a scholar working on Virology, Emergency Medicine and Hepatology, having authored 70 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (30 papers), HIV-related health complications and treatments (22 papers), HIV/AIDS drug development and treatment (20 papers), HIV/AIDS Research and Interventions (12 papers), Hepatitis C virus research (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Virology (429 citations), Emergency Medicine (444 citations) and Infectious Diseases (553 citations). Antonio Chirianni has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Paolo Maggi, Marcello Piazza, Antonio Lillo, Francesco Perilli, Giuseppina Liuzzi, Massimo Clementi, Miriam Gargiulo, Gioacchino Angarano, Pietro Cataldo and Vincenzo Esposito. Their work appears in journals such as Hepatology, Clinical Cancer Research and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.